window._articleFullText = window._articleFullText || {};
window._articleFullText[2334] = "<div class=\"col-lg-12 col-md-12 col-sm-12 col-xs-12\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t<div  style=\"width:100%; float:left;  padding-bottom:0px;\">\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t<div\tstyle=\"width:100%; float:left; min-height:45px; text-align:justify\">\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t\t<a href=\"\" name=\"summary_en\"></a>\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t\t<!--<h2>Summary</h2>-->\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t\t<p><strong>Background</strong>: Previous studies have published the promoting effect of&nbsp;serum and glucocorticoid-regulated kinase 1 (SGK1) in various malignant&nbsp;tumors. However, whether SGK1 promotes gastric cancer remains&nbsp;a mystery.<br /><strong>Aims</strong>: To clarify the function of SGK1 in gastric cancer and its potential&nbsp;regulatory mechanism.<br /><strong>Study Design</strong>: Cell culture study.<br /><strong>Methods</strong>: The SGK1-silenced model was generated in two gastric&nbsp;cancer cell lines and further evaluated their malignant behavior and&nbsp;susceptibility to cisplatin. The interaction between miR-15a-5p and&nbsp;SGK1 was evaluated by the luciferase reporter assay. The knockdown&nbsp;efficiency of SGK1 was confirmed by RT- qPCR and Western blot&nbsp;assays. Cell proliferation rate was assessed with CCK-8 assay, and flow&nbsp;cytometry was used to determine cell cycle progression and apoptosis.<br /><strong>Results</strong>: Western blot data displayed an elevated level of SGK1 in gastric&nbsp;cancer cell lines. Functionally, SGK1 deficiency suppressed gastric&nbsp;cancer cell proliferation (P &lt; .01) by acting on cell-cycle progression.&nbsp;Moreover, SGK1 deficiency suppressed cell invasion and migration of&nbsp;gastric cancer cells (P &lt; .01). Further, the silencing of SGK1 obviously&nbsp;suppressed cell proliferation and induced apoptosis of the cells&nbsp;after cisplatin treatment (P &lt; .01), indicating that SGK1 deficiency&nbsp;facilitated the chemosensitivity of these 2 gastric cancer cell lines to&nbsp;cisplatin. Mechanically, downregulation of SGK1 repressed the cytoplasm-&nbsp;to-nucleus translocation of NF-&kappa;B p65. Interestingly, we found&nbsp;that miR-15a-5p binds to the 3'UTR of SGK1, which was confirmed&nbsp;using luciferase activity assay (P &lt; .05). Moreover, the data suggested&nbsp;that SGK1 reversed the suppression effect of miR-15a-5p on gastric&nbsp;cancer cell migration (P &lt; .01).<br /><strong>Conclusion</strong>: Loss of SGK1 suppresses the malignant behavior of gastric&nbsp;cancer cells and increases cisplatin sensitivity by restraining the&nbsp;NF-&kappa;B signaling pathway. Moreover, SGK1 may exert an inhibitory&nbsp;effect in gastric cancer by being targeted by miR-15a-5p. Therefore,&nbsp;SGK1 may be a prospective target for future gastric cancer therapy.</p>\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t</div>\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t<!--\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t<div\tstyle=\"width:20%; float:left; min-height:150px; padding:10px; padding-top:40px;\">\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t\t\t\t\t<a class=\"selected_menu\" href=\"#summary_en\">Summary</a>\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t</div>\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t-->\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t</div>\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\t\t\t\t\t\t\t\t\t\t\t\t        \t\t\t\n\t\t\n\t\t\t\t\t\t\t\t\t\t\t        \t</div>";
